🇺🇸 Ketamine low-dose in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain — 1 report (10%)
  2. Diplopia — 1 report (10%)
  3. Dizziness — 1 report (10%)
  4. Drug Ineffective — 1 report (10%)
  5. Drug Intolerance — 1 report (10%)
  6. Dysstasia — 1 report (10%)
  7. Hypoaesthesia — 1 report (10%)
  8. Metamorphopsia — 1 report (10%)
  9. Muscular Weakness — 1 report (10%)
  10. Nausea — 1 report (10%)

Source database →

Ketamine low-dose in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ketamine low-dose approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ketamine low-dose in United States?

Cedars-Sinai Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.